Is Brainstorm Cell Stock a Good Investment?
Brainstorm Cell Investment Advice | BCLI |
- Examine Brainstorm Cell's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Brainstorm Cell's leadership team and their track record. Good management can help Brainstorm Cell navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Brainstorm Cell's business and its evolving consumer preferences.
- Compare Brainstorm Cell's performance and market position to its competitors. Analyze how Brainstorm Cell is positioned in terms of product offerings, innovation, and market share.
- Check if Brainstorm Cell pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Brainstorm Cell's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Brainstorm Cell Therapeutics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Brainstorm Cell Therapeutics is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Brainstorm Cell Stock
Researching Brainstorm Cell's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 14.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.45. Brainstorm Cell Ther had not issued any dividends in recent years. The entity had 1:15 split on the 1st of October 2024.
To determine if Brainstorm Cell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Brainstorm Cell's research are outlined below:
| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high historical volatility and very poor performance | |
| Brainstorm Cell Ther may become a speculative penny stock | |
| Brainstorm Cell Ther has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (20.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Brainstorm Cell Ther has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Arbel Irit of 25333 shares of Brainstorm Cell at 0.75 subject to Rule 16b-3 |
Brainstorm Cell Quarterly Accounts Payable |
|
Brainstorm Cell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Brainstorm Cell Therapeutics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brainstorm Cell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Brainstorm Cell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Brainstorm Cell's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-15 | 2023-03-31 | -0.16 | -0.14 | 0.02 | 12 | ||
2022-05-16 | 2022-03-31 | -0.13 | -0.15 | -0.02 | 15 | ||
2016-11-14 | 2016-09-30 | -0.11 | -0.09 | 0.02 | 18 | ||
2015-08-13 | 2015-06-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2024-04-01 | 2024-03-31 | -0.07 | -0.04 | 0.03 | 42 | ||
2022-03-28 | 2021-12-31 | -0.2 | -0.17 | 0.03 | 15 | ||
2021-08-05 | 2021-06-30 | -0.2 | -0.17 | 0.03 | 15 | ||
2019-11-14 | 2019-09-30 | -0.22 | -0.25 | -0.03 | 13 |
Know Brainstorm Cell's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Brainstorm Cell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainstorm Cell Therapeutics backward and forwards among themselves. Brainstorm Cell's institutional investor refers to the entity that pools money to purchase Brainstorm Cell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Securities, Llc | 2024-06-30 | 102 K | Tower Research Capital Llc | 2024-06-30 | 86.6 K | Virtu Financial Llc | 2024-06-30 | 49.6 K | Group One Trading, Lp | 2024-06-30 | 46.8 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 37 K | Wells Fargo & Co | 2024-06-30 | 28.8 K | Creative Planning Inc | 2024-06-30 | 20.9 K | Janney Montgomery Scott Llc | 2024-06-30 | 20.5 K | Jane Street Group Llc | 2024-06-30 | 19.8 K | Armistice Capital, Llc | 2024-06-30 | 7.9 M | Vanguard Group Inc | 2024-06-30 | 1.5 M |
Brainstorm Cell's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.92 M.Market Cap |
|
Brainstorm Cell's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.09) | (4.29) | |
| Return On Capital Employed | 5.97 | 6.27 | |
| Return On Assets | (4.09) | (4.29) | |
| Return On Equity | 3.54 | 3.72 |
Determining Brainstorm Cell's profitability involves analyzing its financial statements and using various financial metrics to determine if Brainstorm Cell is a good buy. For example, gross profit margin measures Brainstorm Cell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Brainstorm Cell's profitability and make more informed investment decisions.
Evaluate Brainstorm Cell's management efficiency
Brainstorm Cell Ther has return on total asset (ROA) of (1.782) % which means that it has lost $1.782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.219) %, meaning that it created substantial loss on money invested by shareholders. Brainstorm Cell's management efficiency ratios could be used to measure how well Brainstorm Cell manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Brainstorm Cell's Return On Capital Employed is increasing as compared to previous years. The Brainstorm Cell's current Return On Equity is estimated to increase to 3.72, while Return On Tangible Assets are projected to decrease to (4.29). The current Total Assets is estimated to decrease to about 4 M. The current Non Current Assets Total is estimated to decrease to about 1.6 M| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.11) | (0.11) | |
| Tangible Book Value Per Share | (0.11) | (0.11) | |
| Enterprise Value Over EBITDA | (10.37) | (10.89) | |
| Price Book Value Ratio | (36.27) | (38.09) | |
| Enterprise Value Multiple | (10.37) | (10.89) | |
| Price Fair Value | (36.27) | (38.09) | |
| Enterprise Value | 158 M | 150.1 M |
The decision-making processes within Brainstorm Cell are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 0.391 |
Basic technical analysis of Brainstorm Stock
As of the 2nd of December, Brainstorm Cell shows the mean deviation of 4.42, and Risk Adjusted Performance of (0.16). Brainstorm Cell Ther technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Brainstorm Cell's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Brainstorm Cell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Brainstorm Cell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Brainstorm Cell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Brainstorm Cell's Outstanding Corporate Bonds
Brainstorm Cell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Brainstorm Cell Ther uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Brainstorm bonds can be classified according to their maturity, which is the date when Brainstorm Cell Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Brainstorm Cell's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Brainstorm Cell's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (1.26) | |||
| Mean Deviation | 4.42 | |||
| Coefficient Of Variation | (449.94) | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.5 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.49) | |||
| Total Risk Alpha | (2.36) | |||
| Treynor Ratio | (1.27) | |||
| Maximum Drawdown | 26.54 | |||
| Value At Risk | (11.88) | |||
| Potential Upside | 9.5 | |||
| Skewness | 0.0444 | |||
| Kurtosis | 1.17 |
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | (1.26) | |||
| Mean Deviation | 4.42 | |||
| Coefficient Of Variation | (449.94) | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.5 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.49) | |||
| Total Risk Alpha | (2.36) | |||
| Treynor Ratio | (1.27) | |||
| Maximum Drawdown | 26.54 | |||
| Value At Risk | (11.88) | |||
| Potential Upside | 9.5 | |||
| Skewness | 0.0444 | |||
| Kurtosis | 1.17 |
Consider Brainstorm Cell's intraday indicators
Brainstorm Cell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brainstorm Cell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Brainstorm Cell time-series forecasting models is one of many Brainstorm Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brainstorm Cell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Brainstorm Stock media impact
Far too much social signal, news, headlines, and media speculation about Brainstorm Cell that are available to investors today. That information is available publicly through Brainstorm media outlets and privately through word of mouth or via Brainstorm internal channels. However, regardless of the origin, that massive amount of Brainstorm data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Brainstorm Cell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Brainstorm Cell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Brainstorm Cell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Brainstorm Cell alpha.
Brainstorm Cell Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Brainstorm Cell Corporate Management
| Antal PearlLendner | VP Counsel | Profile | |
| Daniel Offen | Chief Advisor | Profile | |
| Ibrahim MD | Executive Officer | Profile | |
| Mary Turner | Senior Affairs | Profile | |
| Netta BlondheimShraga | Senior Development | Profile | |
| Stacy Lindborg | CoChief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Brainstorm Cell's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.